Product Image

Nutra-Support Joint

4.8
★ ★ ★ ★ ★
(136 ratings)
Potassium 250 mg
Product Image
Score75
A joint-focused glucosamine, chondroitin, and MSM formula with uncertain potassium details. Its heart-health fit is poor despite the moderate listed mineral amount.
How scoring works
Tablet
Quantity:180 Tablet(s) • (60 servings)
Goals:

Score 75

A joint-focused glucosamine, chondroitin, and MSM formula with uncertain potassium details. Its heart-health fit is poor despite the moderate listed mineral amount.
How scoring works
$58.65($0.97 per serving)
iHerb
$ 58.65
Report prices

Analysis

Glucosamine and chondroitin are the main ingredients and make the formula coherent for joint support. MSM adds a smaller complementary amount, though it does not broaden cardiovascular coverage.

The listed potassium amount is moderate, but the stated form does not identify a recognized potassium compound. That ambiguity makes absorption and elemental-yield assessment less certain.

People seeking a combined joint formula may find the three-tablet serving relevant. Those shopping for heart support or a dependable potassium source should choose a product built around those needs.

Who is it for
  • Adults seeking a multi-ingredient joint formula
  • Users who want glucosamine with chondroitin
  • People willing to take a multi-tablet serving
Best for
  • Joint-support routines
  • Combining glucosamine and chondroitin
  • Users who view potassium as incidental

Pros

  • Provides substantial glucosamine and chondroitin amounts
  • Includes MSM as a complementary joint ingredient
  • Lists each main active separately

Cons

  • Potassium form is unclear
  • Formula does not target cardiovascular pathways
  • Potassium delivery is not the product's main purpose

Warnings

  • Chondroitin may increase bleeding tendency when combined with warfarin or other anticoagulants.
  • Glucosamine can cause digestive discomfort in some users.

Nutrient quality

84 Highest impact

Glucosamine and chondroitin have substantial amounts and closely fit joint support. MSM is modest and the potassium form is unclear, but the combination remains coherent and reasonably balanced.

Ingredient transparency

76 High impact

All active amounts are stated without a hidden blend. The potassium form, chondroitin source, complete directions, and tablet excipients remain incomplete.

Customer satisfaction

68 High impact

The exceptional average rating and moderate review count make the aggregate satisfaction signal reasonably dependable. No detailed review text was provided, so recurring complaints and purpose alignment cannot be assessed.

Value for money

68 High impact

Substantial joint actives support some quality, but the serving cost is relatively high. Modest MSM and incomplete source details weaken competitiveness against clearer joint formulas.

Report analysis

Ingredients

IngredientAmount per serving
Potassium (Glucosamine)
250 mg
Chondroitin Sulfate
1500 mg
Glucosamine Sulfate
1500 mg
Methylsulfonylmethane
300 mg
Gluten Free Adults 18–50 Sugar Free
Report overview
F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyD Value

The listed potassium amount offers a moderate contribution but does not reach the collection benchmark. The label does not identify a recognized potassium compound, so absorption and metabolic utility remain uncertain. Its relatively low serving cost partly offsets the limited dose.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies.
    D'Elia L; Barba G; Cappuccio FP; Strazzullo P · Journal of the American College of Cardiology · 2011
    Meta-analysis247,510 participants11 studies pooledHeart Health forPotassium
  2. Oral potassium supplementation for management of essential hypertension: A meta-analysis of randomized controlled trials.
    Poorolajal J; Zeraati F; Soltanian AR; Sheikh V; Hooshmand E; Maleki A · PloS one · 2017
    Meta-analysis1,213 participants23 studies pooledHeart Health forPotassium
  3. Effect of Potassium Supplementation on Endothelial Function: A Systematic Review and Meta-Analysis of Intervention Studies.
    D'Elia L; Cappuccio FP; Masulli M; La Fata E; Rendina D; Galletti F · Nutrients · 2023
    Meta-analysis332 participants5 studies pooledHeart Health forPotassium
  4. Magnesium and Potassium Supplementation for Systolic Blood Pressure Reduction in the General Normotensive Population: A Systematic Review and Subgroup Meta-Analysis for Optimal Dosage and Treatment Length.
    Behers BJ; Behers BM; Stephenson-Moe CA; Vargas IA; Meng Z; Thompson AJ; Melchor J; Wojtas CN; Rosario MA; Baker JF; Deevers AC; Mouratidis RW; Sweeney MJ · Nutrients · 2024
    Meta-analysisHeart Health forPotassium
  5. Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative.
    Seth A; Mossavar-Rahmani Y; Kamensky V; Silver B; Lakshminarayan K; Prentice R; Van Horn L; Wassertheil-Smoller S · Stroke · 2015
    Cohort study90,137 participantsHeart Health forPotassium
  6. Effect of high potassium diet on endothelial function.
    Blanch N; Clifton PM; Petersen KS; Willoughby SR; Keogh JB · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2015
    Randomized trial35 participantsHeart Health forPotassium
  7. Associations between sodium, potassium, and blood pressure: results from the Hispanic Community Health Study/Study of Latinos, a prospective cohort study.
    Swift SL; Sotres-Alvarez D; Raij L; Wassertheil-Smoller S; Schneiderman N; Llabre M; Zeki Al Hazzouri A; Rundek T; Van Horn L; Daviglus M; Castaneda S; Youngblood M; Mossavar-Rahmani Y; Elfassy T · The American journal of clinical nutrition · 2024
    Cohort study11,429 participantsHeart Health forPotassium
  8. Serum potassium levels provide prognostic information in symptomatic heart failure beyond traditional clinical variables.
    Toledo CC; Vellosa Schwartzmann P; Miguel Silva L; da Silva Ferreira G; Bianchini Cardoso F; Citelli Ribeiro V; Paim LR; Antunes-Correa LM; Carvalho Sposito A; Matos Souza JR; Modolo R; Nadruz W; Fernandes de Carvalho LS; Coelho-Filho OR · ESC heart failure · 2021
    Cohort study178 participantsHeart Health forPotassium
  9. Long-Term Potassium Monitoring and Dynamics in Heart Failure and Risk of Mortality.
    Núñez J; Bayés-Genís A; Zannad F; Rossignol P; Núñez E; Bodí V; Miñana G; Santas E; Chorro FJ; Mollar A; Carratalá A; Navarro J; Górriz JL; Lupón J; Husser O; Metra M; Sanchis J · Circulation · 2019
    Cohort study2,164 participantsHeart Health forPotassium
  10. Finerenone, Serum Potassium, and Clinical Outcomes in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
    Vardeny O; Vaduganathan M; Claggett BL; Desai AS; Jhund PS; Lam CSP; Senni M; Shah SJ; Voors AA; Zannad F; Pitt B; Matsumoto S; Merkely B; Zieroth S; Yilmaz MB; Lay-Flurrie J; Viswanathan P; Horvat-Broecker A; Scalise A; McMurray JJV; Solomon SD · JAMA cardiology · 2025
    Randomized trial6,001 participantsHeart Health forPotassium